A Phase I Study of BPM31510 Plus Vitamin K in Subjects With High-Grade Glioma That Has Recurred on a Bevacizumab Containing Regimen
Latest Information Update: 12 Aug 2021
At a glance
- Drugs Ubidecarenone (Primary) ; Vitamin K
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Gliosarcoma
- Focus Adverse reactions
- 09 Aug 2021 Status changed from active, no longer recruiting to completed.
- 08 Jun 2021 Results of molecular pharmacodynamic assessment of BPM 31510-IV treatment in advanced glioblastoma multiforme patients presented at the 57th Annual Meeting of the American Society of Clinical Oncology
- 02 Jun 2021 According to a Berg Pharma media release, results from this study will be presented at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO).